Latest filing published 17 Sept 2020 for Chinook Therapeutics, INC., €4,835.
Filing timeline
BuySaleInsider track record
Celeste Ferber: trading record in brief
Celeste Ferber discloses dealings in Chinook Therapeutics, Inc. to SEC (Form 4). Over a trading history stretching from 20 May 2019 to 15 September 2020, the count stands at 7 filings.
Every open-market trade on record is a sale: 6 sales worth €31k. Besides market trades, the filings include 1 share grant. So far in 2020, the count stands at no purchases and 2 sales.
The latest filing, published on 17 September 2020, reports an open-market sale of €4,835 in Chinook Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Celeste Ferber
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,396 shares@ US$2.3922.1% of flowCommon StockSEC:0001567619-20-016852:0
- 7,951 shares@ US$2.5577.9% of flowCommon StockSEC:0001567619-20-014727:0
- 22,500 shares0Common StockSEC:0001567619-20-011638:0
- 408 shares@ US$1.161.4% of flowCommon StockSEC:0001567619-19-023144:0
- 1,392 shares@ US$1.315.3% of flowCommon StockSEC:0001567619-19-018458:0
- 1,102 shares@ US$1.314.2% of flowCommon StockSEC:0001567619-19-018458:1
- 2,000 shares@ US$3.2118.5% of flowCommon StockSEC:0001567619-19-011878:0
7 of 7 declarations
